Abstract

Objective: Sudden unexpected death in epilepsy (SUDEP) is a fatal event that ranks second in years of potential life lost among neurological disorders. Seizure-induced respiratory arrest (S-IRA) is the primary instigator leading to death in many SUDEP cases. However, there are currently no effective preventive strategies against S-IRA other than the seizure control. Therefore, it is critical to develop new avenues to prevent SUDEP by investigating the pharmacological interventions of S-IRA. In the present study, we examined the effect of genistein, an isoflavone found in various dietary vegetables, on the incidence of S-IRA in DBA/1 mice.Methods: DBA/1 mice exhibited generalized seizures and S-IRA when subjected to acoustic stimulation. Genistein was intraperitoneally administered alone or in combination with an adrenoceptor antagonist and a serotonin (5-HT) receptor antagonist, respectively. The effects of drug treatments on S-IRA incidence and seizure behaviors were examined.Results: The incidence of S-IRA in DBA/1 mice was significantly reduced 2 h after injection of genistein at 1–90 mg/kg as compared with that in the vehicle control. Genistein could block S-IRA without interfering with any component of seizures, especially at relatively lower dosages. The S-IRA-suppressing effect of genistein was reversed by an α2 adrenoceptor antagonist but was not altered by an α1 antagonist. The inhibitory effect of genistein on S-IRA was not affected by a 5-HT3 or 5-HT2A receptor antagonist.Significance: Our data show that genistein reduces S-IRA incidence and can specifically block S-IRA in DBA/1 mice. Its suppressing effect on S-IRA is dependent on activating α2 adrenoceptors. Our study suggests that genistein, a dietary supplement, is potentially useful to prevent SUDEP in at-risk patients.

Highlights

  • Sudden unexpected death in epilepsy (SUDEP) ranks second in years of potential life lost among common neurological disorders [1]

  • Compared with that in the vehicle control, the incidence of seizure-induced respiratory arrest (S-IRA) was not significantly suppressed by genistein at 0.2 mg/kg (50%, n = 8) (Figure 1). Among those DBA/1 mice whose S-IRA was blocked by genistein, genistein at 1 mg/kg inhibited S-IRA without interfering with any component of audiogenic seizures in 100% of mice, suggesting that genistein blocks S-IRA in these mice

  • We report in this study that systemic administration of genistein, a compound found in many dietary vegetables and a dietary supplement widely available over the counter, lowers the incidence of S-IRA and blocks S-IRA in DBA/1 mice

Read more

Summary

Introduction

Sudden unexpected death in epilepsy (SUDEP) ranks second in years of potential life lost among common neurological disorders [1]. Multiple pathophysiological mechanisms have been proposed for SUDEP [4,5,6,7,8,9]. Both clinical and animal studies demonstrated that seizure-induced respiratory arrest (S-IRA) is the major cause of death in SUDEP [10,11,12,13,14,15,16,17,18,19,20]. Investigating the pathophysiology and pharmacological interventions of S-IRA is of great significance to foster the development of new avenues to prevent SUDEP in patients

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.